3.38
0.16 (4.97%)
Penutupan Terdahulu | 3.22 |
Buka | 3.24 |
Jumlah Dagangan | 8,429 |
Purata Dagangan (3B) | 34,470 |
Modal Pasaran | 8,604,669 |
Harga / Jualan (P/S) | 1.24 |
Harga / Buku (P/B) | 1.43 |
Julat 52 Minggu | |
Tarikh Pendapatan | 26 Aug 2025 - 1 Sep 2025 |
Margin Keuntungan | -85.42% |
Margin Operasi (TTM) | -108.13% |
EPS Cair (TTM) | -2.20 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 10.00% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 9.81% |
Nisbah Semasa (MRQ) | 3.76 |
Aliran Tunai Operasi (OCF TTM) | -4.22 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.29 M |
Pulangan Atas Aset (ROA TTM) | -35.99% |
Pulangan Atas Ekuiti (ROE TTM) | -72.70% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Devices (US) | Menurun | Menurun |
Medical Devices (Global) | Menurun | Menurun | |
Stok | Biomerica, Inc. | - | - |
AISkor Stockmoo
Konsensus Penganalisis | -2.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -2.0 |
Purata Bergerak Teknikal | 2.5 |
Osilator Teknikal | -0.5 |
Purata | -0.50 |
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America. |
|
Sektor | Healthcare |
Industri | Medical Devices |
Gaya Pelaburan | Small Value |
% Dimiliki oleh Orang Dalam | 10.13% |
% Dimiliki oleh Institusi | 5.80% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Bulltick Wealth Management, Llc | 31 Mar 2025 | 17,144 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |